Molecular mechanisms for targeted treatments in fragile X syndrome

Article Properties
Abstract
Cite
Miranda, Isabel, and Randi Hagerman. “Molecular Mechanisms for Targeted Treatments in Fragile X Syndrome”. Rare Disease and Orphan Drugs Journal, vol. 2, no. 3, 2023, https://doi.org/10.20517/rdodj.2023.21.
Miranda, I., & Hagerman, R. (2023). Molecular mechanisms for targeted treatments in fragile X syndrome. Rare Disease and Orphan Drugs Journal, 2(3). https://doi.org/10.20517/rdodj.2023.21
Miranda I, Hagerman R. Molecular mechanisms for targeted treatments in fragile X syndrome. Rare Disease and Orphan Drugs Journal. 2023;2(3).
Refrences
Title Journal Journal Categories Citations Publication Date
Short antisense oligonucleotides alleviate the pleiotropic toxicity of RNA harboring expanded CGG repeats

 Nature Communications
  • Science
  • Science: Science (General)
 25 2021
Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation Cell
  • Science: Biology (General)
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Genetics
 11 2023
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions Journal of Neurodevelopmental Disorders
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 82 2016
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial Nature Medicine
  • Science: Biology (General)
  • Science: Biology (General): Cytology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General): Medical technology
  • Medicine: Medicine (General)
  • Science: Biology (General): Genetics
 52 2021
10.1016/b978-0-323-90036-2.00029-6
Citations
Title Journal Journal Categories Citations Publication Date
Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence Expert Opinion on Pharmacotherapy
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
Citations Analysis
Category Category Repetition
Medicine: Public aspects of medicine: Toxicology. Poisons1
Medicine: Therapeutics. Pharmacology1
The category Medicine: Public aspects of medicine: Toxicology. Poisons 1 is the most commonly referenced area in studies that cite this article.